首页> 外文期刊>Cureus. >A 25-year Experience at an Academic Medical Center in the United States: Are There Racial Disparities in the Prognosis of Patients Diagnosed With Hypopharyngeal Carcinoma?
【24h】

A 25-year Experience at an Academic Medical Center in the United States: Are There Racial Disparities in the Prognosis of Patients Diagnosed With Hypopharyngeal Carcinoma?

机译:在美国学术医疗中心的25年经验:是否存在患者诊断性癌症的患者预后存在种族差异?

获取原文
           

摘要

Introduction This study attempted to identify disparities in outcomes between African American (AA) and Caucasian American (CA) patients treated for hypopharyngeal carcinoma at a tertiary care institution over the past 25 years. Methods An institutional review board (IRB)-approved and Health Insurance Portability and Accountability?Act (HIPPA)-compliant retrospective analysis was performed on patients with squamous cell carcinoma of the hypopharynx treated at our institution between January 1994 and December 2018.?Data regarding demographics, stage, treatment, and follow-up were collected.?Outcomes, including median survival and overall survival, were calculated using the Kaplan-Meier method.?All analyses were performed using the Social Packages for the Social Sciences (SPSS) v. 24 (IBM Corp., Armonk, NY). Results We identified 144 hypopharyngeal carcinoma patients who were treated during this period.?Our patient cohort consisted of 61.8% AA and 35.4% CA (P=0.538).?Overall, 96% of them presented at an advanced stage (Stages III & IV) of the disease, and only 4% presented in the early stages (Stages I & II).?There was no significant difference between AA and CA patients who presented with advanced disease (96.6% vs. 94.1%). In our patient cohort, 15.3% of patients did not receive any therapy; however, 51.4%, 22.9%, and 10.4% of them underwent definitive chemoradiotherapy, definitive surgery, or palliative chemotherapy, respectively. There were no significant differences in patient racial proportions within each treatment group. The median follow-up of the entire cohort was 13 months.?There was no significant difference between the median survival of AA and that of CA patients (16 months vs. 15 months; p=0.917).?Moreover, there was no significant difference in the overall survival between AA and CA patients at three years (27.2% vs. 36.3%; p=0.917) and five years (20.4 % vs. 16.7 %; p=0.917). Conclusions A retrospective review of patients with hypopharyngeal cancer treated at our institution over the previous 25 years did not identify significant racial disparities regarding the stage at presentation or prognosis. This study suggests that when patients have equal access to care, they appear to have a similar prognosis despite racial differences.?Further studies are needed to validate this hypothesis.
机译:简介本研究试图识别在过去25年的第三次护理机构对白种人(AA)和高加索人(AA)和白种人(AA)和白种人(AA)和高加索人(CA)患者治疗的差距。方法制度审查委员会(IRB) - 批准和健康保险携带性和问责制及责任?作用(HIPPA) - 替换回顾性分析对在1994年1月至2018年1月至2018年12月期间在我们的机构治疗的鳞状细胞癌的患者中进行了替换的回顾性分析。关于收集了人口统计学,阶段,治疗和随访。使用Kaplan-Meier方法计算了中位数生存和整体生存期间,包括使用Kaplan-Meier方法计算。使用社会科学(SPSS)v的社会包进行分析。 24(IBM Corp.,Armonk,NY)。结果我们鉴定了在此期间治疗的144名后果癌患者。患者队列由61.8%AA和35.4%CA组成(P = 0.538)。?总体而言,其中96%以先进的阶段呈现(阶段III&IV )疾病,早期阶段仅呈现4%(阶段I&II)。患有晚期疾病的AA和CA患者之间没有显着差异(96.6%vs.94.1%)。在我们的患者队列中,15.3%的患者没有接受任何治疗;然而,51.4%,22.9%和10.4%分别接受了明确的化学疗法,最终手术或姑息化疗。每个治疗组内的患者种族比例没有显着差异。整个队列的中位随访是13个月。AA的中位生存率与CA患者的中位数(16个月与15个月; P = 0.917)之间没有显着差异。(但是,没有显着的AA和Ca患者的整体生存差异为三年(27.2%与36.3%; p = 0.917)和五年(20.4%与16.7%; P = 0.917)。结论在前25岁上对我们在我们的机构治疗的下咽癌患者的回顾性审查并未确定关于介绍或预后阶段的重要种族差异。本研究表明,当患者有平等的护理机会时,尽管种族差异,它们似乎具有类似的预后。需要研究验证这一假设需要研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号